VistaGen Therapeutics Inc. (VTGN)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMEX $
0. 23
-0.01
-4.1667%
$
8.07M Market Cap
- P/E Ratio
- Div Yield
701,500 Volume
-1.6 Eps
$ 0.24
Previous Close Want to track VTGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
VistaGen Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Kevin Roan Stempoint Capita LLP | 616,749 | $1.8M | $150,486.76 | -$1.65M | -91.65% |
 Jay Annis Annis Gardner Whiting Capital Advisors, LLC | 600 | $343 | $142.32 | -$200.68 | -58.51% |
 Douglas E. Morisoli Fairman Group, LLC | 29 | $149 | $6.93 | -$142.07 | -95.35% |
 Zachary Canonico DIADEMA PARTNERS LP | 105,428 | $253,102.19 | $25,123.49 | -$227,978.7 | -90.07% |
 Yuen Man Lee Persistent Asset Partners Ltd. | 26,612 | $76,908.59 | $6,144.71 | -$70,763.88 | -92.01% |
